Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02920866 · ClinicalTrials.gov registry record · NA

Improving Rehabilitation Outcomes After Total Hip Arthroplasty

A NA study of Osteoarthritis and Total Hip Arthroplasty, sponsored by VA Office of Research and Development.

Completed
Registry status
NA
Development phase
95
Enrollment target
1
Study location

NCT02920866: Completed NA study of Osteoarthritis and Total Hip Arthroplasty, sponsored by VA Office of Research and Development.

NCT02920866 is a NA study of Osteoarthritis and Total Hip Arthroplasty that has completed, run by VA Office of Research and Development. The registered enrollment target is 95 participants, below the 817-participant average among 135 other Osteoarthritis trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02920866, a NA study of Osteoarthritis and Total Hip Arthroplasty, has completed, sponsored by VA Office of Research and Development.

COMPLETED
Registry status
NA
Development phase
95 participants
Enrollment target
1
Study location

Study Summary

This study plans to learn more about the effects of physical therapy (PT) following a total hip arthroplasty (THA). The purpose of this study is to compare standard of care PT after THA with a physical therapy program specifically designed to integrate targeted core and hip muscle strength and functional training.

Primary Outcome

Patients will perform a 6MW test, which assesses how far a patient walks in 6 minutes. The 6MW test was chosen as the primary outcome because it captures performance over a period of time that best mimics community ambulation with activities of daily living. Higher numbers indicate better function. The 6MW test is reliable and valid in the post-THA population and can detect small changes in function after THA. 6MW will also be assessed at mid-intervention (POST1, 4 weeks) and 26-week evaluation

Interventions

  • BEHAVIORAL Functional Strength Integration (FSI)
  • BEHAVIORAL Control Group (CON)

Study Locations (1)

Colorado

  • Rocky Mountain Regional VA Medical Center, Aurora, CO - Aurora

Trial Details

FieldValue
Enrollment Target 95 participants
Start Date 2016-11-01
Est. Completion 2022-03-31
Phase NA
VA Office of Research and Development

1,668 total trials

What the finished NCT02920866 record still lists

NCT02920866 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 95 participants, a relatively small participant target, below the 817-participant average among 135 other Osteoarthritis trials with a reported enrollment target (88% lower).

The record links to 2 conditions, with Osteoarthritis appearing as the primary indexed condition, and to 2 interventions - of which Functional Strength Integration (FSI) is the first listed.

NCT02920866 reports a single indexed study location in Colorado.

Frequently Asked Questions

What is clinical trial NCT02920866 about?

NCT02920866 is a clinical study titled "Improving Rehabilitation Outcomes After Total Hip Arthroplasty". This study plans to learn more about the effects of physical therapy (PT) following a total hip arthroplasty (THA). The purpose of this study is to compare standard of care PT after THA with a physical therapy program specifically designed to integrate targeted core and hip muscle strength and funct...

What is the current status of trial NCT02920866?

This trial is currently completed. It is a NA study. The enrollment target is 95 participants. The study started on 2016-11-01. Estimated completion is 2022-03-31.

What conditions does trial NCT02920866 study?

This clinical trial studies the following conditions: Osteoarthritis, Total Hip Arthroplasty.

What interventions are being tested in trial NCT02920866?

The interventions under investigation include: Functional Strength Integration (FSI) (BEHAVIORAL), Control Group (CON) (BEHAVIORAL).

Who is sponsoring clinical trial NCT02920866?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02920866 being conducted?

This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Osteoarthritis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02920866's enrollment target sits among peer trials

95 92nd of 135 higher than 44 of 135 other Osteoarthritis trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Osteoarthritis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03339128 · 95 participants · Phase 2

    Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children

  • NCT03509961 · 95 participants · Phase 2

    The EndRAD Trial: Eliminating Total Body Irradiation (TBI) for NGS-MRD Negative Children, Adolescents, and Young Adults With B-ALL

  • NCT03694756 · 95 participants · NA

    TMEM-MRI: A Pilot Feasibility Study of MRI for Imaging of TMEM in Patients With Operable Breast Cancer

  • NCT04206215 · 95 participants · NA

    Noninvasive Brain Stimulation for Treating Carpal Tunnel Syndrome

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02920866, the US trial registry maintained by the National Library of Medicine. NCT02920866 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.